Formoterol Fumarate Solution
Product Images NDC 0378-1631

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 0378-1631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Formoterol Fumarate Inhalation Solution 20 Mcg/2 mL Vial Carton Label (Image 01)

Formoterol Fumarate Inhalation Solution 20 Mcg/2 mL Vial Carton Label (Image 01)
This is a medication called Formoterol Fumarate Inhalation Solution, available in a 20mcg/2mL vial for oral inhalation only. The solution comes in a carton containing 30 sterile unit-dose vials that are individually wrapped. Each 2mL vial contains active ingredients called formoterol fumarate, USP and inactive ingredients such as citric acid, sodium citrate, sodium chloride, and water. The patient information enclosed in the package has details about the use, dosage, and side effects of the medication. The NDC number is 0378-1631-93 and the medication is an authorized generic for PERFOROMIST® Inhalation Solution. There are also some unidentifiable characters and symbols in the text.*
FDA Label Image

Formoterol Fumarate Structural Formula (Image 02)

Formoterol Fumarate Structural Formula (Image 02)
FDA Label Image

Figure 1: Mean* Fev1 At Day 1 (Image 03)

Figure 1: Mean* Fev1 At Day 1 (Image 03)
This appears to be a table showing information about a study that involved Formoterol Fumarate Inhalation Solution and a placebo, with sample sizes (N) of 123 and 114, respectively. However, without further context or information, it is not possible to provide a more detailed description of the study or its findings.*
FDA Label Image

Figure 2: Mean* Fev1 At Endpoint After 12 Weeks Of Treatment (Image 04)

Figure 2: Mean* Fev1 At Endpoint After 12 Weeks Of Treatment (Image 04)
This is a chart that compares the Mean FEV1 in Liters between a group of 123 people who used Formoterol Fumarate Inhalation Solution 20 mcg and a group of 114 people who used a placebo. The data ranges from 1.20 to 1.80.*
FDA Label Image

Instructions For Use Figure 1 (Image 05)

Instructions For Use Figure 1 (Image 05)
FDA Label Image

Instructions For Use Figure 2 (Image 06)

Instructions For Use Figure 2 (Image 06)
FDA Label Image

Instructions For Use Figures 3 And 4 (Image 07)

Instructions For Use Figures 3 And 4 (Image 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.